Amanote Research

Amanote Research

  • Register
  • Sign In

Role of Oral Cyclophosphamide in the Treatment of Giant Cell Arteritis

Rheumatology- United Kingdom

doi 10.1093/rheumatology/kes127

Full Text

Abstract

Available in

Categories

RheumatologyPharmacology

Date

May 23, 2012

Authors

L. QuartuccioM. MasetG. De MaglioE. PontariniM. FabrisE. MansuttiL. MariuzziS. PizzolittoC. A. BeltramiS. De Vita

Publisher

Oxford University Press (OUP)


Related search

Endovascular Treatment of Intracerebral Giant Cell Arteritis

Frontiers in Neurology
Neurology
2020English

The Treatment of Giant Cell Arteritis in Different Clinical Settings

Frontiers in Immunology
AllergyImmunology
2019English

Treatment of Polymyalgia Rheumatica and Giant Cell Arteritis.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1990English

Update on the Epidemiology and Treatment of Giant Cell Arteritis

Current Treatment Options in Rheumatology
RheumatologyAllergyImmunology
2016English

Giant Cell Arteritis.

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1991English

Giant-Cell Arteritis of the Legs

BMJ
1955English

Diagnosis and Treatment of Giant Cell Arteritis (Temporal Arteritis) – Past, Current and Future Aspects

2011English

Neurological Manifestations of Giant Cell Arteritis

Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova
PsychiatryMental HealthNeurology
2016English

Design of the Tocilizumab in Giant Cell Arteritis Trial

International Journal of Rheumatology
RheumatologyImmunology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote


© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy